By Nadim Daher, Industry Analyst - Medical Imaging, Frost & Sullivan December 6, 2007 - At this year’s RSNA more PACS ...
December 6, 2007 – Patients treated with a rotablator drill less risk of perforation than those treated with the excimer ...
December 6, 2007 — The Circulatory System Devices Advisory Panel to the FDA has recommended approval for the XIENCE V ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
December 6, 2007 - The first commercial implant of the Mitroflow Aortic Pericardial Heart Valve in the U.S. was ...
By Nadim Daher, Industry Analyst - Medical Imaging, Frost & Sullivan December 6, 2007 - More so than in previous years ...
December 6, 2007 - Boston Scientific Corp. welcomed the recommendation of a FDA advisory panel to approve with ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Starion Instruments' TLS3 Tissue Ligating Shears feature Starion’s proprietary thermal welding technology, focusing ...
December 5, 2007 - Bristol-Myers Squibb will divest its medical imaging division as part of an initiative to maximize ...
December 5, 2007 - The United Kingdom's Department of Health said today it will begin a new stroke strategy in which ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
December 4, 2007- Berlin Heart announced the first patient enrollment in the prospective IDE study for its EXCOR Paediatric VAD, a mechanical cardiac support system for critically ill pediatric patients suffering from severe heart failure.
December 4, 2007 - SRSsoft today announced the Cardiovascular Institute of the South (CIS) has selected SRSsoft Clinical ...
December 4, 2007 - In general, drug-eluting stents (DES) achieve better results than bare-metal stents do, U.S ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
December 4, 2007 – The Impella 2.5, a catheter-based heart pump device, supports high-risk patient’s weakened heart in ...
December 4, 2007 - Patients treated with Abbott Laboratories Inc.’s experimental drug-coated heart stent had low rates ...
December 4, 2007 - ELA Medical Inc. intiated U.S. enrollment in the OPTION study (Optimal Anti-tachycardia Therapy in ICD Patients without Pacing Indications), which will evaluate therapies and advanced algorithms in optimizing treatment and managing ICD patients.
December 05, 2007
